The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 31 | — | 20.1x | Below average | |
Growth | 22 | -20.3% | 5.6% | Below average | |
Quality | 7 | -130.3% | 7.6% | Below average | |
Safety | 31 | 0.7x | 0.4x | Below average | |
Capital Return | 41 | — | 2.19% | Near average | |
Momentum | — | — | — | No data | |
Sentiment | — | — | — | No data |
Korro Bio, Inc. is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy Korro Bio, Inc. shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
Korro Bio stock saw stability in its average price target at 19.57 dollars despite a new analyst joining the coverage recently, indicating a consensus on the current fair value. Data shows a notable Analyst Dispersion in estimates between a low of 10 and a high of 30 dollars, reflecting uncertainty regarding the revenue timeline and expected operational results, especially with expectations of losses in EPS for upcoming periods.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.